221 related articles for article (PubMed ID: 21452026)
21. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
22. [Once-weekly teriparatide treatment on osteoporosis].
Nakano T
Clin Calcium; 2014 Jan; 24(1):100-5. PubMed ID: 24369286
[TBL] [Abstract][Full Text] [Related]
23. The teriparatide in the treatment of severe senile osteoporosis.
Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
[TBL] [Abstract][Full Text] [Related]
24. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Teriparatide for osteoporosis associated with lifestyle-related diseases].
Fukumoto S
Clin Calcium; 2014 Nov; 24(11):1701-5. PubMed ID: 25355155
[TBL] [Abstract][Full Text] [Related]
25. Clinical update on teriparatide.
File E; Deal C
Curr Rheumatol Rep; 2009 Jul; 11(3):169-76. PubMed ID: 19604460
[TBL] [Abstract][Full Text] [Related]
26. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
27. Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening.
Oteo-Álvaro Á; Matas JA; Alonso-Farto JC
Orthopedics; 2011 Sep; 34(9):e574-7. PubMed ID: 21902160
[TBL] [Abstract][Full Text] [Related]
28. Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34).
Jolette J; Attalla B; Varela A; Long GG; Mellal N; Trimm S; Smith SY; Ominsky MS; Hattersley G
Regul Toxicol Pharmacol; 2017 Jun; 86():356-365. PubMed ID: 28389324
[TBL] [Abstract][Full Text] [Related]
29. [Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis].
Marumo K; Saito M
Nihon Rinsho; 2011 Jul; 69(7):1264-9. PubMed ID: 21774369
[TBL] [Abstract][Full Text] [Related]
30. The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial.
Jepsen DB; Ryg J; Hansen S; Jørgensen NR; Gram J; Masud T
Osteoporos Int; 2019 Sep; 30(9):1827-1836. PubMed ID: 31309239
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
[TBL] [Abstract][Full Text] [Related]
32. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.
Ohtori S; Inoue G; Orita S; Yamauchi K; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Nakamura J; Ishikawa T; Miyagi M; Kamoda H; Suzuki M; Kubota G; Sakuma Y; Oikawa Y; Inage K; Sainoh T; Takaso M; Ozawa T; Takahashi K; Toyone T
Spine (Phila Pa 1976); 2012 Nov; 37(23):E1464-8. PubMed ID: 22872218
[TBL] [Abstract][Full Text] [Related]
33. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
[TBL] [Abstract][Full Text] [Related]
34. Combination antiresorptive and osteoanabolic therapy for osteoporosis: we are not there yet.
Cusano NE; Bilezikian JP
Curr Med Res Opin; 2011 Sep; 27(9):1705-7. PubMed ID: 21740288
[TBL] [Abstract][Full Text] [Related]
35. Anabolic therapy for osteoporosis.
Bilezikian JP
Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
[TBL] [Abstract][Full Text] [Related]
36. [Daily subcutaneous injection of teriparatide : the progress and current issues].
Yano S; Sugimoto T
Clin Calcium; 2014 Jan; 24(1):35-43. PubMed ID: 24369278
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic targets for osteoporosis.
Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of osteoporosis with PTH].
Takeuchi Y
Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
[TBL] [Abstract][Full Text] [Related]
39. Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.
Macdonald HM; Nishiyama KK; Hanley DA; Boyd SK
Osteoporos Int; 2011 Jan; 22(1):357-62. PubMed ID: 20458576
[TBL] [Abstract][Full Text] [Related]
40. Teriparatide: a review.
Quattrocchi E; Kourlas H
Clin Ther; 2004 Jun; 26(6):841-54. PubMed ID: 15262455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
